| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.01B | +14.2% |
| Cost of Revenue | $719.2M | +74.1% |
| Gross Profit | $288.6M | -38.5% |
| R&D Expense | $6.4M | +10.3% |
| SG&A Expense | $126.8M | +100.6% |
| Operating Income | -$53.5M | -115.6% |
| Pre-tax Income | $210.6M | -45.9% |
| Income Tax | $78.9M | +34.0% |
| Net Income | $103.2M | -68.7% |
| EPS (Basic) | $0.10 | -94.6% |
| EPS (Diluted) | $0.09 | -94.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $93.2M | -60.8% |
| Accounts Receivable | $130.3M | +22.1% |
| Inventory | $417.6M | +92.0% |
| Current Assets | $859.8M | +32.6% |
| Total Assets | $10.19B | +215.5% |
| Current Liabilities | $789.0M | +193.7% |
| Long-term Debt | $960.6M | +218.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$176.0M | -159.2% |
| Capital Expenditures | $1.04B | +218.9% |
| Investing Cash Flow | -$445.3M | -95.1% |
| Financing Cash Flow | $492.4M | +2513.7% |
| Free Cash Flow | -$1.22B | -3990.6% |
| Total Liabilities |
| $3.01B |
| +218.0% |
| Stockholders' Equity | $6.26B | +251.0% |